CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 3 Insider Initial Statement of Ownership
- 8-K Event Other events
- 8-K Event Other events
- 4 Open-market sale EVP, Research & CSO sold 7,900 shares at $53.60 ($423,408)
- 4 Open-market sale EVP, Research & CSO sold 2,340 shares at $48.00 ($112,320)
- 4 Open-market sale EVP, Research & CSO sold 5,560 shares at $44.80 ($249,086)
- 4 Open-market sale Chief Business Officer sold 6,944 shares at $63.44 ($440,531)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 4 Open-market sale EVP, Research & CSO sold 7,900 shares at $63.74 ($503,577)
- 8-K Event Results of operations
- 8-K Event Material agreement · Unregistered share sale
- 4 Grant or award CFO acquired 25,000 shares (grant or award)
- 4 Grant or award EVP, Research & CSO acquired 30,000 shares (grant or award)
- 4 Option exercise Chief Medical Officer acquired 10,000 shares (option exercise)
- 4 Grant or award Chief Administrative Officer acquired 20,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 111,000 shares (grant or award)
- 4 Option exercise Chief Medical Officer acquired 10,000 shares (option exercise)
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
Page 30 of 41 · 806 filings